1020 related articles for article (PubMed ID: 23870513)
1. FOXM1 (Forkhead box M1) in tumorigenesis: overexpression in human cancer, implication in tumorigenesis, oncogenic functions, tumor-suppressive properties, and target of anticancer therapy.
Wierstra I
Adv Cancer Res; 2013; 119():191-419. PubMed ID: 23870513
[TBL] [Abstract][Full Text] [Related]
2. The transcription factor FOXM1 (Forkhead box M1): proliferation-specific expression, transcription factor function, target genes, mouse models, and normal biological roles.
Wierstra I
Adv Cancer Res; 2013; 118():97-398. PubMed ID: 23768511
[TBL] [Abstract][Full Text] [Related]
3. FoxM1 as a novel therapeutic target for cancer drug therapy.
Xu XS; Miao RC; Wan Y; Zhang LQ; Qu K; Liu C
Asian Pac J Cancer Prev; 2015; 16(1):23-9. PubMed ID: 25640357
[TBL] [Abstract][Full Text] [Related]
4. miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer.
Tan X; Fu Y; Chen L; Lee W; Lai Y; Rezaei K; Tabbara S; Latham P; Teal CB; Man YG; Siegel RS; Brem RF; Fu SW
Oncotarget; 2016 Jan; 7(1):293-307. PubMed ID: 26588055
[TBL] [Abstract][Full Text] [Related]
5. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
[TBL] [Abstract][Full Text] [Related]
6. FOXM1, a typical proliferation-associated transcription factor.
Wierstra I; Alves J
Biol Chem; 2007 Dec; 388(12):1257-74. PubMed ID: 18020943
[TBL] [Abstract][Full Text] [Related]
7. The Forkhead Box m1 transcription factor stimulates the proliferation of tumor cells during development of lung cancer.
Kim IM; Ackerson T; Ramakrishna S; Tretiakova M; Wang IC; Kalin TV; Major ML; Gusarova GA; Yoder HM; Costa RH; Kalinichenko VV
Cancer Res; 2006 Feb; 66(4):2153-61. PubMed ID: 16489016
[TBL] [Abstract][Full Text] [Related]
8. The transcription factor FOXM1c binds to and transactivates the promoter of the tumor suppressor gene E-cadherin.
Wierstra I
Cell Cycle; 2011 Mar; 10(5):760-6. PubMed ID: 21311221
[TBL] [Abstract][Full Text] [Related]
9. FOXM1 promotes the epithelial to mesenchymal transition by stimulating the transcription of Slug in human breast cancer.
Yang C; Chen H; Tan G; Gao W; Cheng L; Jiang X; Yu L; Tan Y
Cancer Lett; 2013 Oct; 340(1):104-12. PubMed ID: 23856032
[TBL] [Abstract][Full Text] [Related]
10. FOXM1 and its Oncogenic Signaling in Gastric Cancer.
Wang H; Huang C
Recent Pat Anticancer Drug Discov; 2015; 10(3):270-9. PubMed ID: 26081924
[TBL] [Abstract][Full Text] [Related]
11. Deletion of Forkhead Box M1 transcription factor reduces malignancy in laryngeal squamous carcinoma cells.
Chen W; Yuan K; Tao ZZ; Xiao BK
Asian Pac J Cancer Prev; 2011; 12(7):1785-8. PubMed ID: 22126565
[TBL] [Abstract][Full Text] [Related]
12. FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells.
Hamurcu Z; Ashour A; Kahraman N; Ozpolat B
Oncotarget; 2016 Mar; 7(13):16619-35. PubMed ID: 26918606
[TBL] [Abstract][Full Text] [Related]
13. Role of FoxM1 in the Progression and Epithelial to Mesenchymal Transition of Gastrointestinal Cancer.
Zhang J; Niu Y; Huang C
Recent Pat Anticancer Drug Discov; 2017; 12(3):247-259. PubMed ID: 28440206
[TBL] [Abstract][Full Text] [Related]
14. Deletion of Forkhead Box M1 transcription factor from respiratory epithelial cells inhibits pulmonary tumorigenesis.
Wang IC; Meliton L; Ren X; Zhang Y; Balli D; Snyder J; Whitsett JA; Kalinichenko VV; Kalin TV
PLoS One; 2009 Aug; 4(8):e6609. PubMed ID: 19672312
[TBL] [Abstract][Full Text] [Related]
15. Endothelial cell-specific deletion of transcription factor FoxM1 increases urethane-induced lung carcinogenesis.
Balli D; Zhang Y; Snyder J; Kalinichenko VV; Kalin TV
Cancer Res; 2011 Jan; 71(1):40-50. PubMed ID: 21199796
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of forkhead box M1 transcription factor (FOXM1) is a potential prognostic marker and enhances chemoresistance for docetaxel in gastric cancer.
Okada K; Fujiwara Y; Takahashi T; Nakamura Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Mori M; Doki Y
Ann Surg Oncol; 2013 Mar; 20(3):1035-43. PubMed ID: 23054116
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of FoxM1 by MnSOD Overexpression Contributes to Cancer Stem-Like Cell Characteristics in the Lung Cancer H460 Cell Line.
Fu Z; Cao X; Yang Y; Song Z; Zhang J; Wang Z
Technol Cancer Res Treat; 2018 Jan; 17():1533033818789635. PubMed ID: 30111255
[TBL] [Abstract][Full Text] [Related]
18. Metadherin/Astrocyte elevated gene-1 positively regulates the stability and function of forkhead box M1 during tumorigenesis.
Yang L; He K; Yan S; Yang Y; Gao X; Zhang M; Xia Z; Huang Z; Huang S; Zhang N
Neuro Oncol; 2017 Mar; 19(3):352-363. PubMed ID: 27923917
[TBL] [Abstract][Full Text] [Related]
19. Silencing transcription factor FOXM1 represses proliferation, migration, and invasion while inducing apoptosis of liver cancer stem cells by regulating the expression of ALDH2.
Chen L; Wu M; Ji C; Yuan M; Liu C; Yin Q
IUBMB Life; 2020 Feb; 72(2):285-295. PubMed ID: 31580537
[TBL] [Abstract][Full Text] [Related]
20. FoxM1: at the crossroads of ageing and cancer.
Laoukili J; Stahl M; Medema RH
Biochim Biophys Acta; 2007 Jan; 1775(1):92-102. PubMed ID: 17014965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]